Community news|10/11/16

Endocrine disruptors: promoting recognition and awareness of this occupational risk

Home > The news of EUROGIP and occupational risks in Europe > Endocrine disruptors: promoting recognition and awareness of this occupational risk

While the Member States are to meet on 18 November to discuss the amended proposal of the European Commission regarding the criteria for definition of endocrine disruptors, the ETUI is publishing a guide to improve knowledge of their impact on workers’ health.

The European Trade Union Institute’s publication aims to raise trade union leaders’ and policymakers’ awareness of this risk largely unknown to the public and to workers. It also aims to draw attention to the shortcomings of European legislation on matters of workplace safety. Accordingly, the guide will be central to the campaign organized by the European trade unions throughout 2016 and 2017 on the theme of “Cancer and work”.

Download the guide (in French)

Discover other news

Community news


OSH measures key to prevent violence and harassment at work

More than one in five workers in the 25 countries surveyed have experienced violence and harassment at work, according to a new report by the ILO. Creating an environment free of these problems requires “a cooperative approach and social dialogue within companies on occupational health and safety (OHS)”.

Community news


Lead and diisocyanates: Council approves new limit values

The new directive adopted today reduces the occupational exposure limit values for lead and its compounds, which are toxic to reproduction, by a factor of five, and introduces new limit values for diiosocyanates, to which 4.2 million workers are exposed and which can cause asthma and skin diseases.



OS&H in Europe: where are we now?

So where are we in Europe when it comes to health and safety at work? That's the question we put to William Cockburn Salazar, the new Executive Director of the European Agency for Safety and Health at Work (EU-OSHA), in the first episode of the EUROGIP Discussions.